GULZAR, Kashif et al.
 Safety profile of COVID-19 Medication in Chronic Kidney disease patients: renal and hepatic dysfunction associated with anti-viral and Tocilizumab use. Single Centre experience.
<strong>Medical Research Archives</strong>, [S.l.], v. 13, n. 8, aug. 2025.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/6832" target="_new">https://esmed.org/MRA/mra/article/view/6832</a>&gt;. Date accessed: 05 dec. 2025.
doi: <a href="https://doi.org/10.18103/mra.v13i8.6832">https://doi.org/10.18103/mra.v13i8.6832</a>.